guidelines pharmacologic therapy weight regain after bariatric surgery glp-1 Rebound or Retention: A Meta-Analysis of the Discontinuation of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Other Anti-obesity Drugs Pharmacologic treatment of obesity in

What that looks like in practice: some people notice shifts in energy and how their body composition responds before the scale moves much, since the goal is metabolic, not just water weight

The development of GLP-1 medicines has transformed the therapeutic options for patients with type 2 diabetes (T2D) who are unable to achieve sufficient glucose control with existing treatments

Our team will work closely with you to combine semaglutide therapy with personalized nutrition counseling and fitness recommendations, ensuring you achieve your goals safely and effectively

Nicolini 2010)

Despite all the positive outcomes from these types of drugs, GLP-1 therapy alone is not some type of magic diabetes management solution

All Polygon Peptides products are for laboratory and scientific research use only